Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering
Fatemeh Sabet Sarvestani, Ramin Yaghobi, Mohsen Khosravi Maharlooei, Mehdi Golshan, Mohammad Hossein Karimi · 2026
Read Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering by Fatemeh Sabet Sarvestani, Ramin Yaghobi, Mohsen Khosravi Maharlooei, Mehdi Golshan, Mohammad Hossein Karimi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13453144.txt.
Description
Fatemeh Sabet Sarvestani and co-authors review a personalized route to treating type 1 diabetes in a 2026 paper. The disease destroys the pancreas's insulin-making beta cells, and insulin shots or pumps manage sugar without restoring the body's own control or stopping the attack.
Transplanting insulin-producing islets could cure, but rejection, donor shortage, and harsh immune suppression stand in the way. Framed by predictive, preventive, and personalized medicine, the review covers forecasting who is at risk, protecting grafts with local immune calming, and patient-matched materials and cell therapies. Recent biomaterial advances feature throughout.
Catalog record
| CREATOR | Fatemeh Sabet Sarvestani, Ramin Yaghobi, Mohsen Khosravi Maharlooei, Mehdi Golshan, Mohammad Hossein Karimi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 90 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |